Webinar: German innovation funding (NUB) and the new benefit assessment

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process. 
The new benefit assessment by G-BA and IQWiG will create a significant change in the ability for early commercialization in Germany at the same time as it will provide an opportunity to perform a government funded clinical study. 

Webinar will be conducated by Dr Martin Braun.

Agenda: 
- Introduction to NUB
- Process and evidence requirements for the new benefit assessment 
- Analysis of the first publications from GBA regarding the new process
- Q&A